AMI Cardiogenic Shock

Clinical Evidence

Key Findings from the National Cardiogenic Shock Initiative Study1,2,3

  • Identify and support cardiogenic shock early
  • Turn down titriation of inotropes aggressively
  • Identify inadequate left ventricular (LV) support and escalate, if CPO <0.6
  • Identify right ventricular (RV) dysfunction early and support
  • Systematically use right heart catheter (RHC) to guide therapy

Clinical Evidence of Impella® Systems: Pathway to Class I Recommendation

Clinical evidence of Impella systems has established safety and effectiveness and validated best practices.

The Procedure

Learn more about femoral access, explant techniques and other best practises.

References

  1. Tehrani, B.N., et al. (2019). JACC. 73, 1659-1669.
  2. Basir, M.B., et al. (2019). Catheter Cardiovasc Interv, 93(7), 1173-1183.
  3. O’Neill, W.W., TCT 2020.

NPS-2632

This information is intended for use by customers, patients, and healthcare professionals in Europe only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside Europe, and the information from other sites you visit may not be appropriate for use in Europe.